Below is a description of the main pharmaceutical products for human use that we represent, promote, distribute and/or market under license by Grupo Profármaco in Central America and the Dominican Republic:
| |
Name |
Laboratory |
Description |
Marketing |
|
|
|
Mefasa Farma |
Non-sedating antihistamine. Allergic rhinitis, urticaria and allergic dermatitis. |
Licensed Products.
Distribution.
Representation.
|
|
|
|
|
Mefasa Farma |
L-Carnitine to prevent and treat muscular and systemic disorders due to a...
|
Licensed Products.
Distribution.
Representation.
|
|
|
|
|
Mefasa Farma |
Specific antibiotic for uncomplicated lower urinary tract infections. |
Licensed Products.
Distribution.
Representation.
|
|
|
|
|
Ferrer Grupo |
Pharyngoamigdalitis. |
Distribution.
Representation.
|
|
|
|
|
Daiichi – Sankyo |
Physiological treatment of digestive disorders. |
Distribution.
Representation.
|
|
|
|
Ferrer Grupo |
Antispasmodic, anticholinergic and gastroprokinetic. |
Distribution.
Representation.
|
|
|
|
|
Faes Farma |
Appetite enhancer, stimulant. |
Distribution.
Representation.
|
|
|
|
|
Daiichi – Sankyo |
Anti-inflammatory spray and analgesic for treatment of sports injuries. |
Distribution.
Representation.
|
|
|
|
|
Faes Farma |
Antianaemic. |
Distribution.
Representation.
|
|
|
|
|
Faes Farma |
Antianaemic. |
Distribution.
Representation.
|
|
|
|
|
Ferrer Grupo |
Physiological stabiliser of the nervous system. |
Distribution.
Representation.
|
|
|
|
Ferrer Grupo |
Anti-diarrhoeal. |
Distribution.
Representation.
|
|
|
|
|
Daiichi – Sankyo |
Anti-inflammatory, percutaneous antithrombotic (gel or cream). Also in FORTE presentation. |
Distribution.
Representation.
|
|
|
|
|
Daiichi – Sankyo |
Analgesic, Anti-inflammatory and antipyretic. |
Distribution.
Representation.
|
|
|
|
|
Daiichi – Sankyo |
Immunostimulant. Prophylaxis of recurrent respiratory tract infections. |
Distribution.
Representation.
|
|
|
|
Ferrer Grupo |
Antiinfective for acne treatment. |
Distribution.
Representation.
|
|
|
|
Ferrer Grupo |
Antineuritic. |
Distribution.
Representation.
|
|
|
|
Ferrer Grupo |
Triglyceride reduction agents. |
Distribution.
Representation.
|
|
|
|
|
Faes Farma |
Stimulant, Antiasthenic. |
Distribution.
Representation.
|
|
|
|
|
Ferrer Grupo |
Psychic normaliser. |
Distribution.
Representation.
|
|
|
|
|
Faes Farma |
Anxiolytic |
Distribution.
Representation.
|
|
|
|
Ferrer Grupo |
Treatment of neurological damage of ischaemic, traumatic or degenerative origin. |
Distribution.
Representation.
|
|
|
|
|
Faes Farma |
Physical and mental stimulant. Antiasthenic. |
Distribution.
Representation.
|
|
|
|
|
Faes Farma |
Venous vasoprotectant |
Distribution.
Representation.
|
|
|
|
|
Faes Farma |
Venous vasoprotectant |
Distribution.
Representation.
|
|
|
|
Ferrer Grupo |
Antimycotic. |
Distribution.
Representation.
|
|
